0
0
0
Stop STALLING Act
3/13/2024, 3:50 PM
Summary of Bill S 148
The Stop STALLING Act, also known as Bill 118 s 148, is a piece of legislation introduced in the US Congress with the aim of addressing delays in the approval process for infrastructure projects. The acronym STALLING stands for Streamlining Transportation Approvals, Limiting Litigation, and Expediting Necessary Reviews to Secure Infrastructure Long-Term Act.
The main goal of the Stop STALLING Act is to streamline the approval process for transportation projects by reducing unnecessary delays and expediting reviews. The bill aims to achieve this by setting deadlines for environmental reviews and permitting decisions, as well as limiting the ability of third parties to file lawsuits that could further delay projects.
Additionally, the Stop STALLING Act includes provisions to improve coordination between federal agencies involved in the approval process, as well as measures to increase transparency and accountability in decision-making. The bill also seeks to prioritize projects that have the greatest potential to improve transportation infrastructure and create jobs. Overall, the Stop STALLING Act is intended to address inefficiencies in the approval process for infrastructure projects and expedite the development of much-needed transportation improvements. The bill has garnered bipartisan support in Congress and is currently under consideration for passage.
The main goal of the Stop STALLING Act is to streamline the approval process for transportation projects by reducing unnecessary delays and expediting reviews. The bill aims to achieve this by setting deadlines for environmental reviews and permitting decisions, as well as limiting the ability of third parties to file lawsuits that could further delay projects.
Additionally, the Stop STALLING Act includes provisions to improve coordination between federal agencies involved in the approval process, as well as measures to increase transparency and accountability in decision-making. The bill also seeks to prioritize projects that have the greatest potential to improve transportation infrastructure and create jobs. Overall, the Stop STALLING Act is intended to address inefficiencies in the approval process for infrastructure projects and expedite the development of much-needed transportation improvements. The bill has garnered bipartisan support in Congress and is currently under consideration for passage.
Congressional Summary of S 148
Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act or the Stop STALLING Act
This bill makes it an unfair method of competition to submit an objectively baseless petition to the Food and Drug Administration (FDA) in an attempt to interfere with a competitor's application for market approval of a drug.
The bill authorizes the Federal Trade Commission to sue an individual or entity that submits such a petition to the FDA. A party found liable in such a lawsuit shall be subject to civil penalties, such as a fine of up to $50,000 for each day that the FDA spent reviewing the baseless petition.
Read the Full Bill
Current Status of Bill S 148
Bill S 148 is currently in the status of Bill Introduced since January 30, 2023. Bill S 148 was introduced during Congress 118 and was introduced to the Senate on January 30, 2023. Bill S 148's most recent activity was Placed on Senate Legislative Calendar under General Orders. Calendar No. 21. as of March 1, 2023
Bipartisan Support of Bill S 148
Total Number of Sponsors
1Democrat Sponsors
1Republican Sponsors
0Unaffiliated Sponsors
0Total Number of Cosponsors
16Democrat Cosponsors
10Republican Cosponsors
6Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill S 148
Primary Policy Focus
HealthPotential Impact Areas
- Administrative remedies
- Business ethics
- Civil actions and liability
- Competition and antitrust
- Department of Health and Human Services
- Drug safety, medical device, and laboratory regulation
- Food and Drug Administration (FDA)
- Licensing and registrations
- Prescription drugs
- Public participation and lobbying
Alternate Title(s) of Bill S 148
Stop STALLING Act
A bill to enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition, and facilitate the efficient review of petitions filed in good faith to raise legitimate public health concerns, and for other purposes.
Stop STALLING Act
Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act
Stop STALLING Act
Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act
Comments
Sponsors and Cosponsors of S 148
Latest Bills
National Law Enforcement Officers Remembrance, Support, and Community Outreach Act
Bill HR 309August 21, 2026
National Oceanic and Atmospheric Administration Sexual Harassment and Assault Prevention Improvements Act of 2025
Bill HR 2406August 21, 2026
No Antisemitism in Education Act of 2026
Bill HR 8476August 21, 2026
Chesapeake Bay Watershed Advancement for Training, Education, Restoration, and Science (WATERS) Act
Bill HR 6893August 21, 2026
To provide for the equitable settlement of certain Indian land disputes regarding land in Illinois, and for other purposes.
Bill HR 2827August 21, 2026
Local Communities & Bird Habitat Stewardship Act of 2026
Bill HR 3276August 21, 2026
To reauthorize the Young Women’s Breast Health Education and Awareness Requires Learning Young Act of 2009.
Bill HR 4541August 20, 2026
Stop Insider Trading Act
Bill HR 7008August 20, 2026
National Defense Authorization Act for Fiscal Year 2027
Bill HR 8800August 20, 2026
Main Street Capital Access Act
Bill HR 6955August 20, 2026